http://rdf.ncbi.nlm.nih.gov/pubchem/reference/7380867

Outgoing Links

Predicate Object
contentType Journal Article|Research Support, Non-U.S. Gov't|Review
endingPage 1224
issn 1420-682X
1420-9071
issueIdentifier 6
pageRange 1209-1224
publicationName Cellular and molecular life sciences : CMLS
startingPage 1209
hasFundingAgency http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_d29184df8844e34b460482b1b6dbad96
http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_e6b3a96648f043b52c0bafaa5cd95f62
isSupportedBy http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_33794d7e2560241a0e0805d61fb57ad8
http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_cd70dcc224de811c848cff40b9600d68
http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_e39883c90ecabafd8b3b0fe395db6f44
http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_c83a8d2771a8a3cbafc32d02cd53e112
bibliographicCitation Bayliss R, Choi J, Fennell DA, Fry AM, Richards MW. Molecular mechanisms that underpin EML4-ALK driven cancers and their response to targeted drugs. Cellular and Molecular Life Sciences. 2016 Jan 11;73(6):1209–24. doi: 10.1007/s00018-015-2117-6.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0003-0604-2773
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f8ddf5ab1d363825a768dc3df0629695
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_40f0a093fcc4f9501d7d7eb7d65f3556
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4100e6d19480178f6ddff3b359c9f636
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_963400cc0bf6411ee05a9f2d03e12562
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7ec296378bbb28ca0c2b37b34894e016
date 2016-01-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier https://pubmed.ncbi.nlm.nih.gov/PMC4761370
https://pubmed.ncbi.nlm.nih.gov/26755435
https://doi.org/10.1007/s00018-015-2117-6
isPartOf https://portal.issn.org/resource/ISSN/1420-9071
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/20436
https://portal.issn.org/resource/ISSN/1420-682X
language English
source https://pubmed.ncbi.nlm.nih.gov/
https://scigraph.springernature.com/
https://www.crossref.org/
title Molecular mechanisms that underpin EML4-ALK driven cancers and their response to targeted drugs
discusses http://id.nlm.nih.gov/mesh/M0228330
http://id.nlm.nih.gov/mesh/M0023875
http://id.nlm.nih.gov/mesh/M0328256
http://id.nlm.nih.gov/mesh/M0028143
http://id.nlm.nih.gov/mesh/M0019678
http://id.nlm.nih.gov/mesh/M0513130
http://id.nlm.nih.gov/mesh/M0457532
http://id.nlm.nih.gov/mesh/M0493054
http://id.nlm.nih.gov/mesh/M0013835
http://id.nlm.nih.gov/mesh/M0372594
http://id.nlm.nih.gov/mesh/M0028195
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7168
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_b23065537a07b03ba7e2ca1197841172
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_8ec03999a28cdaaeb3c7910122bdd5b6
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_9812d46bb63b7ca1d737789c0e1430b0

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID27436
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID238

Total number of triples: 51.